関連する実験動画

Updated: Jul 23, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K

組織ポリペプチド抗原（TPA）を非侵襲的膀胱癌バイオマーカーとして

Neeraj Kumar Fuloria1, Kamal Narain2, Anupam Biswas3

  • 1Faculty of Pharmacy, AIMST university, Bedong, Kedah 08100, Malaysia.

Clinica chimica acta; international journal of clinical chemistry
|January 15, 2026
PubMed
まとめ

組織ポリペプチド抗原（TPA）は、非侵襲的な膀胱癌サーベイランスとして有望視されています。標準化は、特に診断精度と患者管理の改善のためのマルチマーカーアルゴリズムにおける臨床使用にとって鍵となります。

キーワード:
バイオマーカー標準化膀胱癌臨床検査医学前分析的調和組織ポリペプチド抗原

さらに関連する動画

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model06:12

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

7.6K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

15.5K

関連する概念動画

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.